Advanced in Classical Hodgkin Lymphoma
Advanced in Classical Hodgkin Lymphoma
1275 York Ave, 
New York, NY 

Overview

Christopher Forlenza is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Forlenza is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Histiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Classical Hodgkin Lymphoma.

Specialties
Pediatric Hematology Oncology
Licenses
Student in an Organized Health Care Education/Training Program in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Health First
  • HMO
  • POS
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1275 York Ave, New York, NY 10065

Additional Areas of Focus

Dr. Forlenza has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
View 19 Less Clinical Trials
Similar Doctors
Advanced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
Advanced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
195 Little Albany St, 
New Brunswick, NJ 
 (31.8 miles away)
Languages Spoken:
English

Peter Cole is a Pediatric Hematologist Oncology provider in New Brunswick, New Jersey. Dr. Cole is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Classical Hodgkin Lymphoma.

Experienced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
Experienced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
703 Main St, 
Paterson, NJ 
 (14.6 miles away)
Languages Spoken:
English

Alissa Kahn is a Pediatric Hematologist Oncology provider in Paterson, New Jersey. Dr. Kahn is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Sickle Cell Disease, Febrile Neutropenia, Hereditary Spherocytosis, and Thalassemia.

Experienced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
Experienced in Classical Hodgkin Lymphoma
Pediatric Hematology Oncology
1275 York Ave, 
New York, NY 
 (0.1 miles away)
Languages Spoken:
English

Pamela Merola is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Merola is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Desmoplastic Small Round Cell Tumor, Sickle Cell Disease, and Langerhans Cell Histiocytosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Forlenza's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile